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The development and validation of a chromatography rate model for an industrial multicomponent chromatographic
bioseparation is presented. The model is intended for use in a process scenario to allow speciﬁc variables critical to
product  quality to be studied. The chromatography provides impurity clearance whilst producing a complex product
composed  of six closely related variants of a dimer protein therapeutic (∼30 kDa), with their monomer subunits in a
speciﬁc  ratio. Impurity removal is well understood, however, achieving the correct monomer subunit ratio can pose
a  puriﬁcation challenge. We utilise a stepwise approach to develop a model for studying the effect of feed material
variability  on product quality. Scale down experiments are completed to quickly generate data for estimating model
parameters,  before an iterative procedure is employed where the industrial process is used to reﬁne parameters in
a  sequential manner, until model predictions exhibit satisfactory agreement with experimental data. Final model
predictions  were in good agreement with experimental product quality (within 3%). The results demonstrate how
good  understanding of an industrial process can help facilitate model development when an exhaustive descrip-
tion  is not required, despite considering a chromatographic bioseparation with crude feed material and challenging
puriﬁcation  objectives.© 2013 The Authors. Published by Elsevier B.V. 
Keywords: Process systems modelling; Quality by design; Chromatography modelling; Hydrophobic interaction chro-
matography;  Puriﬁcation process development; Therapeutic protein
within constricted timelines to meet time to market con-
Open access under CC BY license.1.  Introduction
Advances in healthcare over the past half century have been of
immense  beneﬁt to the quality of life for an increasing world
population. The rapid growth in protein therapeutics has
played  a key role in this, and is predicted to continue with sev-
eral  hundred clinical candidate proteins currently estimated
in  company pipelines (Kelley, 2009) of which many serve sig-
niﬁcant  unmet medical needs (Shukla et al., 2007). However,
despite  several decades of effort to improve R&D efﬁciency and
performance,  the process for bringing a new biopharmaceuti-
cal  product to market remains an expensive, time-consuming,
and risky proposition (Lightfoot and Moscariello, 2004).
         
∗ Corresponding author. Tel.: +44 020 7679 3802; fax: +44 020 7383 2348.
E-mail  address: e.sorensen@ucl.ac.uk (E. Sorensen).
Received  2 July 2013; Received in revised form 21 October 2013; Accep
0263-8762 © 2013 The Authors. Published  by Elsevier B.V.  
http://dx.doi.org/10.1016/j.cherd.2013.10.022
Open access undeChromatographic separations are the workhorse of thera-
peutic  protein puriﬁcation (Kelley, 2007), but their design and
operation  is a challenging task. An optimal, safe and economic
process  must be found quickly somewhere in an extremely
large  parameter space which simply cannot be explored in
depth  using traditional experimental methodologies. Down-
stream  process development currently depends heavily upon
empirical  experimentation interpreted using heuristic knowl-
edge  to arrive at an acceptable process (Lightfoot and
Moscariello, 2004). The amount of material available to work
with  is often limited, and the work must be completed     
ted 22 October 2013
straints.  Furthermore, US Food and Drugs Administration
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Notation
Cm mobile phase concentration (mg/ml)
Csp stationary phase concentration (mg/ml)
CF compression factor
DA apparent axial dispersion coefﬁcient (cm2/s)
F mobile phase ﬂowrate (ml/min)
ka equilibrium constant
L  column length (cm)
NC number of components
Np number of theoretical plates
qs saturation capacity (mg/ml)
q  settled resin concentration (mg/ml)
t0 retention time of an unretained small molecule
(s)
t time (s)
u  interstitial velocity (cm/s)
V0 void volume (ml)
VC column volume (ml)
T total column porosity
  peak width of an unretained molecule at half of
the  peak height
i  component identiﬁer
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cFDA) regulations require that the basic separation scheme is
xed prior to clinical trials, early on in the overall development
rocess.
The  FDA is now encouraging the use of quality by design
QbD)  principles during process development and operation
US  Food and Drug Administration, 2006). Key to a QbD
pproach is a thorough understanding of process inputs and
heir  impact on performance, the relationship between the
rocess  and the products’ critical quality attributes (CQA),
nd  the association between the CQA’s and a product’s clin-
cal  properties (Jiang et al., 2010). The expected beneﬁt from
 QbD approach is an increase in the assurance of product
uality, and in turn, the FDA will allow manufacturers greater
exibility  to operate with lower regulatory burden, enabling
ontinuous process improvement, as well as greater robust-
ess.
Mechanistic modelling can be a useful tool for studying the
mpact  of process parameters on process performance and
roduct  CQA’s. Altering the values of process parameters may
e  difﬁcult or even impossible to accomplish experimentally,
.g. feed stream composition, but is trivial in a model based
pproach. In addition, simulations can be completed quickly
nd  efﬁciently which is valuable in an industrial scenario
here time and material is often limited, and the fundamen-
al  knowledge gained by their application can be used to better
nderstand,  and reduce, processing risks.
The equations used to mathematically describe the chro-
atographic puriﬁcation of proteins are well understood (e.g.
aczmarski  et al., 2001; Guiochon, 2002; Brooks and Cramer,
992;  Seidel-Morgenstern, 2004). The systematic development
f  a chromatographic model has been described for many  dif-
erent systems, including ion exchange (Melter et al., 2008),
ydrophobic interaction (McCue et al., 2008; Nagrath et al.,
011),  and protein A chromatography (Ng et al., 2012). The
ssue  of efﬁcient model calibration has been thoroughly
ddressed (Teoh et al., 2001; Persson et al., 2006; Susanto
t  al., 2006; Osberghaus et al., 2012a). Mechanistic models of
hromatography have been successfully employed to simulatenumerous  case studies (Kaczmarski et al., 2002; Mollerup et al.,
2007; Osberghaus et al., 2012b). In addition, there are useful
examples  of using chromatography models for optimisation
(Degerman et al., 2006, 2007; Ng et al., 2012), scale up (Gerontas
et  al., 2010), design space characterisation (Degerman et al.,
2009;  Gétaz et al., 2013b), as well as robustness, uncertainty
and  sensitivity analysis (Jakobsson et al., 2005; Borg et al.,
2013).
As  a result of the progress in modelling chromatography
that has been made over the last decade, systems with crude
feed  material, containing product, product-related impurities
(e.g.  oxidation, deamidation, acetylation, dimerisation), and
process-related impurities (e.g. antifoam, DNA, protein, virus)
have  recently been considered (e.g. Gétaz et al., 2013a; Nfor
et  al., 2013). The complexity of the industrial feed material
in  these studies means that the model development pro-
cedures  involve conducting an extensive range of detailed
experiments which may  not be suitable in certain scenar-
ios.  One such scenario in industry is where the majority
of  process development has already taken place, but there
remains  a desire to develop understanding of a key feature of
a  bioseparation. The experimental effort required to develop
an  exhaustive model may  discourage a mechanistic modelling
approach  considering time and material constraints.
In this work, a chromatography model for predicting prod-
uct  quality in an industrial multicomponent bioseparation
is  developed and validated. The model is intended for use
in  a process scenario to allow speciﬁc variables critical to
product  quality to be studied. The chromatography utilises
a  hydrophobic interaction retention mechanism to purify a
multicomponent product from a complex mixture of impuri-
ties.  Process parameters were predeﬁned prior to this work.
Impurity  removal is well understood and therefore a model
description of this feature of the chromatography is not
required.  However, the step must also deliver the multi-
component product composed of six closely related variants
of  a dimer protein therapeutic (∼30 kDa) with their monomer
subunits in a speciﬁc ratio. Variability in the feed material
poses  a puriﬁcation challenge, and consequently, there is a
risk that the products’ monomer subunit ratio will not meet
product  quality speciﬁcations incurring signiﬁcant losses.
Therefore, a model which can study product quality as a func-
tion  of the load material concentration and composition is
developed  and validated in this work. A systematic procedure
is  used to determine key model parameter values, ﬁrst using
targeted  experimental studies to quickly generate experimen-
tal  data for estimation of model parameters, before employing
an  iterative procedure where laboratory scale column runs
of  the industrial process using real feed material are used to
reﬁne  parameters in a sequential manner until model predic-
tions  exhibit satisfactory agreement with experimental data.
We  demonstrate how good understanding of an industrial pro-
cess can facilitate model development, despite considering a
chromatographic bioseparation with crude feed material and
challenging  puriﬁcation objectives.
2.  Problem  description
The hydrophobic interaction chromatography (HIC) consid-
ered  in this work is a complex separation with challenging
puriﬁcation objectives. The product of interest is a disulphide
linked  dimer protein molecule (MW = 30 kDa), comprised of
two  monomer subunits. Three variations of the monomer
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Fig. 1 – The product is a disulphide linked dimer protein
therapeutic (MW  ≈ 30 kDa), comprised of two monomer
subunits. Three variations of the monomer subunit exist
due  to slight variations in the amino acid sequence, here
denoted  A, A¯ and B, resulting in six different forms of the
product.  All six closely related variants of the dimer protein
therapeutic must be present in the ﬁnal product, with their
monomer  subunits in a speciﬁc ratio.subunit exist due to slight variations in the amino acid
sequence, here denoted A, A¯ and  B. This results in six possible
isoforms of the dimer (AA, A¯A¯,  AA¯, A¯B,  AB and BB) as shown in
Fig.  1. The corresponding analytical chromatogram is shown in
Fig. 2A. Each form is an active component of the ﬁnal product
which  must contain a speciﬁc ratio of the monomer sub-
units,  (A + A¯)  : B, i.e. not just one product form at a given total
amount  is required, but six closely related dimer variants, with
a  speciﬁc ratio of their monomer subunits. Speciﬁcally, sub-
unit  B must account for between 25% and 45% of all monomer
subunits in the product, i.e. 0.25 < B < 0.45. In addition to the
product,  approximately 30% of the HIC feed material was
product  related impurities including the individual monomer
subunits  (A, A¯and  B), incorrectly formed product species (I1, I2,
I3, I4), and host cell related contaminants consisting of mainly
host  cell protein. The corresponding analytical chromatogram
is  shown in Fig. 2B.
Fig. 2 – Analytical chromatogram of (A) the product and (B)
the  feed material. (Axis values removed for conﬁdentiality
purposes).3.  Systematic  model  development
3.1.  Determining  modelling  approach
Minimising the time and amount of material required to
develop,  validate, solve and determine model solutions is
extremely  important, as process development timelines are
typically  very constricted (Steinmeyer and McCormick, 2008).
Especially so, as many  simulations may  be required to map
the  impact of process parameters on process performance and
product  CQA’s (Degerman et al., 2006; Karlson et al., 2004).
Thus,  we  aimed to minimise the necessary experimental and
computational effort required to model the HIC and our ulti-
mate  goal was  not to develop the most exact model description,
but  to develop a model with sufﬁcient accuracy for use in indus-
try.
3.2.  Mathematical  model
An equilibrium dispersive model was  used to simulate the HIC
(Guiochon et al., 1994). This model assumes that the mass
transfer  kinetics between the mobile phase moving through
the  column bed and the particles is inﬁnitely fast. Thus the
concentration of component i in the mobile phase is equal
to  the average concentration of component i in the intra-
particular mobile phase, and the axial dispersion coefﬁcient is
replaced with an apparent axial dispersion coefﬁcient which
includes  the contribution from the mass transfer kinetics.
The  model has the following additional assumptions; (i) the
column  is one-dimensional (radially homogeneous), (ii) the
chromatographic separation is isothermal and adiabatic, (iii)
the compressibility of the mobile phase is negligible and thus
the  velocity proﬁle is ﬂat, and (iv) the mass transfer parame-
ters  are independent of component concentration.
With the assumption that the column is radially homoge-
neous, the differential mass balance in the bulk mobile phase
is  described by (Guiochon et al., 1994):
∂Cm
i
∂t
+ (1  − T)
T
· ∂C
sp
i
∂t
+ u · ∂C
m
i
∂z
=  DA ·
∂2Cm
i
∂z2
∀ i
= 1, 2, . . .,  NC and z ∈ (0, L) (1)
where Cm
i
is the concentration of component i in the mobile
phase,  t is the time, T is the total column porosity, C
sp
i
is
the  concentration of component i in the stationary phase, u
is  the interstitial velocity, z is the axial coordinate, DA is the
apparent  axial dispersion coefﬁcient, NC is the number of com-
ponents  in the system, and L is the column length. ∂Cm
i
/∂t is
the  rate per unit volume of accumulation of component i in
the  mobile phase, ((1 − T)/T) · (∂Cspi /∂t) is the rate per unit vol-
ume  of accumulation of component i in the stationary phase,
u  · (dC/dz) · (∂Cm
i
/∂z) is the rate per unit volume of mass trans-
fer  by convection down the column, and DA · (∂2Cmi /∂z2) is the
rate  per unit volume of mass transfer by dispersion and parti-
cle  mass transfer kinetics lumped into one term. The apparent
axial  dispersion coefﬁcient can be estimated from the number
of  theoretical plates of the column, Np (Guiochon et al., 1994):
DA = uL2Np (2)The number of theoretical plates is determined directly
from  the chromatogram of an unretained small molecule
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tccording to the following equation (Synder and Kirkland,
008):
p = 5.54
(
t0

)2
(3)
here t0 is the retention time of an unretained small molecule
nd   is the peak width of the unretained molecule at half of
he  height of the chromatogram peak (both determined exper-
mentally).  The total column porosity, T, is deﬁned as the ratio
etween  the void volume, V0, and the column volume, VC:
T = V0
VC
(4)
The void volume, V0, can be determined from the product
f  the retention time of an unretained small molecule (deter-
ined  experimentally), t0, and the mobile phase ﬂowrate, F:
0 = t0F (5)
The boundary conditions for Eq. (1) are the following
Guiochon et al., 1994):
At  the inlet of the column, i.e. at z = 0, the mobile phase
oncentration, Cm
i
, depends on convection and dispersion:
uCmi –DA
∂Cm
i
∂z
]
|z=0 = uCmi,0 ∀ i = 1, 2, . . .,  NC (6)
here Cm
i,0 is the inlet concentration.
At  the outlet of the column, only convective transport is
onsidered:
∂Cm
i
∂z
|z=L = 0 ∀i = 1, 2, . . .,  NC (7)
An initial condition is also required to solve Eq. (1) which
tates  that the rate per unit volume of accumulation in the
obile  phase of component i at t = 0 is zero at all points interior
o  the column:
∂Cm
i
∂t
=  0 0 < z < L ∀i = 1, 2, . . .,  NC (8)
In this work, protein adsorption onto the stationary phase
as  modelling using a competitive Langmuir adsorption
sotherm (Seidel-Morgenstern, 2004):
i =
qs · ka,i · Cmi
1 +
∑
ka,i · Cmi
∀i = 1, 2, . . .,  NC z ∈ (0, L) (9)
here qs is the resin saturation capacity, and ka,i is the equilib-
ium  constant of component i, and qi represents the amount
f  protein adsorbed per unit volume of settled resin. When
he  adsorption isotherm (Eq. (9)) is linked with the differential
ass  balance in the bulk mobile phase (Eq. (1)), the amount of
rotein  adsorbed per unit volume of settled resin, qi, is con-
erted  to the amount of protein adsorbed per unit volume of
tationary  phase in the packed bed, Csp
i
:
sp
i
= CF · qi
(1 − T)
∀i  = 1, 2, . . .,  NC z ∈ (0, L) (10)
here dividing qi by (1 − T) accounts for the phase ratio
Mollerup, 2008), and multiplying qi by a compression fac-
or,  CF, deﬁned as the ratio between settled bed volume andpacked  bed volume, accounts for bed compression (Gerontas
et  al., 2010). All model equations are implemented and
solved  using the dynamic simulation tool gPROMSTM (Process
Systems  Enterprise, 2013). Discretisation of the column in the
axial  coordinate is done using the built-in orthogonal colloca-
tion  on ﬁnite element method (OCFEM).
3.3.  Parameter  estimation  and  model  validation
We  used a systematic approach to model calibration, as
illustrated in Fig. 4. In the procedure, targeted micro
well experimentation is utilised to estimate the adsorption
isotherm parameters, qs and ka,i. Scale down  column stud-
ies  are used to determine the total column porosity, T, and
give  an initial estimate of the mass transfer, DA, parame-
ters  of the system (Fig. 4 Steps 1 and 2). Then an iterative
procedure is employed, where laboratory scale column runs
(7  ml  CV, 7.4 cm bed height) of the industrial process using
untreated feed material are used to reﬁne parameters in a
sequential  manner until model predictions exhibit satisfac-
tory  agreement with experimental data (illustrated in Fig. 4
Steps  2 and 3, results for the HIC described in detail in Section
4).  Such a procedure is required when model predictions after
the  initial calibration effort (Fig. 4 Steps 1 and 2) are not sat-
isfactory,  because generating more  pure material for further
model  development is normally prohibitively costly, and using
data  from the actual industrial process is a superior method
from  our industrial perspective, as will become clear in the fol-
lowing  section. Experimental results were  used to estimate the
values  of model parameters using the ‘parameter estimation’
entity  in gPROMS based on the SRQPD sequential quadratic
programming code. Parameter estimation was  based on the
maximum  likelihood formulation, which determines values
for  the uncertain physical and variance model parameters
that maximise the probability that the model will predict the
measurement  values obtained from the experiments. The sta-
tistical variance model of constant variance was  used in this
case  (Process Systems Enterprise, 2013).
4.  Model  development  of  HIC
chromatography
In the following section we  describe the application of the
procedure  outlined above to the industrial multicomponent
hydrophobic interaction chromatography considered in this
work.
4.1.  Generation  of  puriﬁed  materials  for  model
calibration experiments
One of the key challenges of developing a mechanistic model
of  industrial chromatographic processes is the limited avail-
ability  of puriﬁed material, which is required for many  tasks
in  the overall effort to bring a protein therapeutic to market
e.g.  drug trials, stability studies, toxicology studies, etc. We
had  to generate our own protein solutions for model develop-
ment  experiments from bulk feed material. Following initial
puriﬁcation  by pseudo afﬁnity capture, the material contained
the  6 product forms of interest, as well as a range of product
related  impurities and host cell proteins (HCP’s). The product
forms  were  further puriﬁed and isolated from impurities over
multiple  runs on the hydrophobic interaction chromatogra-
phy  considered in this work. Multiple runs were  required as it
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Fig. 3 – (A) Experimental comparison between column runs
using  feed material with and without impurities (7 ml  CV,
7.4 cm bed height, 4.2 CV/h, inlet
concentration = 0.34 mg/ml, load challenge = 2 mg/ml).
Similar product form percentages and overlapping A280 nm
trace during wash and elution indicates that impurities
have minimal impact on separation of product forms and
can  be neglected in the model. (B) Chromatogram showing
the  A280 nm trace and the percentage of product related
impurities and product in samples taken every CV during a
standard HIC run, determined by phenyl RP HPLC. The
ﬁgure  shows that the majority of impurities in the feed
material  elute from the column during the load phase,
product forms begin to elute from the column at the end ofwas  particularly challenging to separate the product isoform
BB  from closely related product related impurities. Fractions
were  taken every column volume (CV) and analysed by CEX
HPLC  in order to determine the isoform distribution of the
sample.  Multiple samples with a range of isoform distribu-
tions  were  generated in this way,  and later pooled in order
to  generate material with desired isoform distributions for
development  experiments. Conﬁrmation of removal of prod-
uct  related impurities and HCP’s was  determined by phenyl RP
HPLC. We  were  unable to generate pure samples of each prod-
uct  isoform which prevented determining traditional single
component  isotherms. We therefore required an approach to
model development which used multicomponent mixtures of
the  six product forms. This involved (1) measuring isotherms
competitively and (2) using an advanced parameter estimation
facility  to ﬁt the experimental data to a competitive isotherm
model.
4.2.  Assumptions
The similar amino acid sequence of two of the monomer sub-
units  (A and A¯) results in similar separation properties of the
product  isoforms AA, A¯A¯, AA¯ and the product isoforms A¯B,  AB.
In  order to simplify the modelling problem, the six product
isotherms were  reduced in the model to three components:
AA,  AB and BB. The chromatography cycle is divided into dif-
ferent  steps (see Appendix for detailed description). Firstly,
the  product is applied to the column (load step), then buffer
without  any product is applied (wash step), before bound pro-
tein  is collected by applying an elution buffer (elution step).
We  assumed that all product isoforms that remain bound to
the  column after the load and wash steps are subsequently
collected in the elution step. This assumption was  conﬁrmed
experimentally. Our approach also assumed that the product
related  impurities and HCP’s in the feed stream had a negligi-
ble  impact on the separation of the product of interest, as the
impurities  are observed to ﬂow through during the load phase
of  the chromatographic cycle (Fig. 3B). To conﬁrm this we also
compared  the product form distributions in fractions collected
every  CV during HIC runs with and without impurities in the
feed  material. Runs were  identical in all other aspects e.g. load
challenge,  product form concentrations and wash length. We
found that the impurities had no effect on the product distri-
butions  (Fig. 3A). In addition, by comparing the UV traces in
Fig.  3A, one can clearly see where the impurities are ﬂowing
through  during the load step, before the two UV traces merge
and  are in exact agreement.
4.3.  Initial  model  calibration  experiments  and
determination of  parameter  values
The apparent axial dispersion coefﬁcient, DA, and total col-
umn  porosity, T, were  determined from pulse injections of
a  small unretained molecule using Eq. (2) to Eq. (5). The
determined total column porosity value, 0.9, was  in agree-
ment  with previous literature estimations for the same resin
(McCue  et al., 2007). The number of theoretical plates, Np, was
determined  as 309 with a plate height of 0.0239 cm,  result-
ing  in an apparent axial dispersion coefﬁcient, DA, value of
0.0001  cm2/s.
We  made special effort to determine accurate isotherm
parameters at the start of model development, as the accuracy
of  the equilibrium isotherm is the most important part of the
chromatographic model (Mollerup et al., 2009). Competitionthe  load phase and continue throughout the wash.
between product forms was a signiﬁcant part of the separa-
tion,  as the multiple product forms were closely related and
had  similar adsorption properties. It was  important to capture
these  competitive effects in the adsorption isotherm model
for  simulation accuracy. We used batch adsorption experi-
mental  studies on a microwell plate to generate competitive
adsorption data (i.e. the amount of component i adsorbed per
unit  volume of settled resin, qi (mg/ml), as a function of the
concentration of all components in the liquid (mobile phase),
Cm
i
, (mg/ml)), which was ﬁtted with a competitive Langmuir
isotherm model (Eq. (9), using gPROMS to estimate the satu-
ration  capacity, qs, and equilibrium constants, ka,i.
Batch adsorption in a microwell plate is tedious requir-
ing  labour intensive experiments, and can give inaccurate
results (Seidel-Morgenstern, 2004). However, it can be auto-
mated  using robotic liquid handling to reduce experimental
burden, and is simpler than most alternative methodologies
(e.g. perturbation method, dispersed front analysis, peak ﬁt-
ting)  which are difﬁcult when applied to multicomponent
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Step 1. Initial model calibration experiments
i) Pulse  injection  of  a sm all  un retai ned  molec ule on  sm all  sca le co lumn
to determ ine  and
ii) High throughput batch adsorption on a  96-well plate to generate
multi comp onent comp etiti ve ad sorpti on data
Step  2. Deter mine para met er val ues
i) and , , parameter  es timation  experim entally determined
multi comp onent comp etiti ve ad sorpti on data  from st ep 1
ii)  and  calculated from equ ations 2 - 5 us ing  exp erimentally
determi ned  and  from step 1
Step  3. Model validation  an d cali bra tion experi ments
i) Condu ct small  scale  column runs  (in this work  7ml  CV, 7.4 cm bed
height )
START
END
Yes
Step 5. Refine mo del  par ameter s
i) Use prod uct  form pe rce ntages
(from step 4) and para meter
estim ati on (g PROMS ) to  refine
, , and  where neces sary
ii) Use manual ref inement if required
Step  4. Va lidate  model  predicti ve capa city
Com pare si mulated  and ex perim entally determined :
i) Produ ct form percentages  in eluti on peak
ii) Produ ct fo rm percentages  in samples  taken during  load  and wash
Are mode l
predictions
sati sfactory
?
No
Fig. 4 – Flow diagram showing the model development
procedure used in this work. We utilised a stepwise
approach, ﬁrst using targeted scale down  experimental
studies to quickly generate data for estimation of model
parameters (Steps 1 and 2). We  then employed an iterative
procedure where laboratory scale column runs of the
industrial process were  used to reﬁne parameters in a
sequential  manner until model predictions were  in
agreement with experimental data (Steps 3, 4 and 5).
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Fig. 5 – Experimental and simulated multicomponent
competitive adsorption isotherms at a range of load
material product distributions, as shown on the graphs in
the order AA%:AB%:BB%. The experimental data is from
micro  well plate batch adsorption followed by CEX HPLC
analysis.  All experimental points were  repeated in
the  product isoforms in the elution pool is a key objective of the
Table 1 – Experimentally determined model parameter
values after initial model calibration.
Parameter name Parameter
symbol
Value  StDev
AA equilibrium constant ka,1 5.31 0.58
AB  equilibrium constant ka,2 1.49 0.16
BB  equilibrium constant ka,3 0.52 0.07
Saturation  capacity qs 6.45 0.36
Total  column porosity T 0.9 –
Apparent  axial
dispersion coefﬁcient
DA 0.0001 –eparations. Only frontal analysis is relatively straightforward,
ut  was unfeasible in this work due to high costs and limited
vailability of required material. Our exact methodology for
he  batch adsorption studies was  based upon previous work
n  high throughput screening of chromatographic separations
Coffman  et al., 2008), and is described in the Appendix. All
atch  adsorption experiments were repeated in triplicate, and
verages  are shown in this paper.
To ensure that the experimental data used to ﬁt the com-
etitive  Langmuir model contained competitive information,
e  varied the product form distribution in the load mate-
ial  used in the batch adsorption experiments. Each graph in
ig.  5 shows adsorption data from microwell experiments con-
ucted at a different load material product form distribution,
hown in the ratio AA%:AB%:BB% in the top left hand cor-
er  of each graph. Note that although the graphs show the
ound  concentration of the product form as a function of its
obile  phase concentration, the mobile phase concentration
f  the other two product forms are also affecting the bound
oncentration. The effects of competition for binding sites is
lear when the graphs in Fig. 5 are compared. In graph C, thetriplicate and standard error is shown on graphs.
BB stationary phase concentrations are signiﬁcantly higher,
especially  compared to Graph B. This is due to the favourable
product distribution of the load material resulting in fewer
competing components, allowing more  BB to bind (graph C
load  material 20% AA:25% AB:55% BB, graph B load material
28%  AA:59% AB:13% BB.
The  estimated isotherm parameter values are shown in
Table  1. The standard deviations of the estimated parameters
are  approximately ten percent, indicating there is still some
uncertainty around the parameter values. The coefﬁcient of
determination,  r2, for the model ﬁt to experimental data was
0.96,  which was  found to be sufﬁcient for satisfactory agree-
ment  between model predictions and experimental data as
shown  in Fig. 5, given the inherent uncertainties of the batch
adsorption  studies.
4.4.  Model  validation  and  calibration  experiments
The product form distribution in the elution peak, and in sam-
ples  taken from the column outlet every column volume (CV)
during  the load and the wash, was  measured during experi-
mental  small-scale column runs using CEX HPLC. The ability
of  the model to predict these product form distributions was
an  important and industrially relevant test to validate model
accuracy,  since achieving a speciﬁc percentage distribution ofCompression  Factor CF 1.25 –
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Table 2 – Model validation runs: product percentage in load, load concentration, wash length, and load challenge.
Run identiﬁer Load challenge
(mg/ml resin)
Load
concentration
(mg/ml)
Wash  length (CV) Percentage AA Percentage AB Percentage BB
A 1.5 0.26 10 35 35 30
B 2.4 0.44 10 14 38 48
C 2.2 0.35 10 40 44 16
D 1 0.4 3 38 20 42
 E 1 0.11 3.2
chromatography. This data was  also suitable for model calibra-
tion  should the ﬁrst iteration of the model give unsatisfactory
predictions.
4.5.  Validation  of  model  predictive  capacity
The ﬁrst iteration of the model was  unable to give satisfactory
predictions of the chromatographic process after the initial
model  calibration, as shown in Fig. 6A. This was  not unex-
pected,  as although we  had spent extra effort ensuring that
the  isotherm parameters were  accurate, we  used a lumped
mass  transfer coefﬁcient and had determined its value using
the  residence time of a unretained molecule (NaCl) that
was  signiﬁcantly smaller than the protein, and thus would
be  expected to experience faster mass transfer. We could
have  considered using a more  complex model (Kaczmarski
et  al., 2001), and/or used alternative experimental approaches
to  determining mass transfer parameters more  accurately,
e.g.  conducting multiple pulse injections of the product at
non-binding  conditions, or using van Deemter plot method-
ology,  etc. (Muller-Spath et al., 2011; Ng et al., 2012). However,
applying  these techniques to this industrial separation was
Fig. 6 – Experimental and simulated product form
distributions during load, wash and in ﬁnal elution peak.
(A)  Before model reﬁnement. (B) After model reﬁnement.
The apparent axial dispersion coefﬁcient and the AA
adsorption constant were modiﬁed from 0.0001 cm2/s to
0.003  cm2/s, and 5.31 to 3.5, respectively.38 20 42
problematic. For example, we could not ﬁnd any non-binding
conditions suitable for pulse injections of the product which
did  not signiﬁcantly alter the system, and the lack of any
pure  component material, the highly competitive system and
closely  related isotherms of the product forms meant that the
van  Deemter plot method was  not practical. In addition, we
were  conscious that there may  also have been unidentiﬁed
phenomenon occurring which could potentially affect these
approaches,  for example proteins unfolding on the HIC sur-
face.  Therefore, we took an alternative approach as discussed
in  the following section.
4.6.  Reﬁne  model  parameters
We used data from the previously conducted model validation
run  of the industrial process to reﬁne the model parameters.
Experimentally determined product distributions in fractions
taken  every CV were used to estimate the new value of the
apparent  axial dispersion coefﬁcient, DA, using the ‘parame-
ter  estimation’ entity in gPROMS. The previously determined
value,  estimated from the number of theoretical plates of the
column,  Np, was used as an initial guess. Adsorption isotherm
parameters, qs and ka,i, were  reﬁned manually, guided by the
previously  determined values, standard deviations and exper-
imental  product distributions. This method made optimal use
of validation data, and meant no further experiments were
required  other than for further model validation. Runs of the
industrial  process are straightforward to conduct, can be left
to  run unsupervised with minimal preparation time, and can
use  feed material that needs no pre treatment and is readily
available. This part of our approach can be easily integrated
with  traditional process development where column runs of
the  industrial process are conducted regularly. The drawback
of  such a procedure is that it can result in sub optimal param-
eter  values. Estimating model parameters directly from the
industrial  process under normal operation was  not possible
without  prior knowledge of suitable initial values, due to the
complexity  of the feed material and separation considered in
this work.
We  found that model predictions were  in good agreement
with experimental results after one iteration of reﬁning the
model  parameters using model validation run data, shown in
Figs.  6 and 7. The ﬁgures show the good agreement between
the  predicted and experimentally determined product form
distributions in fractions taken every CV, and in the elu-
tion  peak. The apparent axial dispersion coefﬁcient and the
AA  equilibrium constant were  modiﬁed from 0.0001 cm2/s to
0.003  cm2/s, and 5.31 to 3.5, respectively.
Model  validation studies (including the model reﬁnement
run) were conducted using qualiﬁed scale down  columns
to  provide a rigorous test of model accuracy. The ﬂowrate,
bed  height and mobile phase conditions were  kept constant
throughout. The composition of the load material, total load
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Fig. 7 – Experimental and simulated product form
distributions during load, wash and in ﬁnal elution peak in
model validation runs. (7 ml  CV, 7.4 cm bed height, 4.2
CV/h, load details shown in Table 2).
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foncentration, load challenge and wash length were varied as
escribed in Table 2. Results are presented in Table 3. Vali-
ation  run A was  chosen to give a good representation of the
soform  distributions experienced in normal load material and
he  load challenges used during day-to-day operation of the
hromatography (Fig. 7A). The model gave very accurate pre-
ictions  of the product form percentages in samples taken
uring  the load and the wash phase, and was  able to accu-
ately  predict the ﬁnal products’ monomer subunit ratio in
he  elution peak. The isoform distributions chosen for runs B
nd C were  chosen to provide a challenge for the model, and
ould  rarely be experienced during day-to-day operation. It
as important to test these artiﬁcially created, rare load con-
itions  in order to understand the limitations of the model.
he  model gave good predictions across the extended range
f  conditions, especially for the case study C (Fig. 7C). The
ifference between model predictions and experimental data
or validation run B (Fig. 7B) was  due to the very challenging
Table 3 – Model validation: experimental and predicted
product quality.
Run identiﬁer Experimental %B Simulation %B
A 10 10
B 14 17
C 7 6
D 44 46
E 34 37isoform distribution in the load material, in particular that
product  isoform BB occupied 48% of the load, combined with
a  high load concentration and load challenge. The model
slightly overestimated the percentage of AB during the wash
length,  which was  attributed to tailing of BB that was  not cap-
tured  by the model. This was  not observed during studies with
fresh  feed material, and thus it is likely that a small amount
of  product was  damaged during the multiple applications,
buffer exchanges and concentration steps used to generate
the  feed material for validation studies. Runs D and E were
conducted to test model predictions at shorter wash lengths
more  applicable to producing a product of the desired quality,
and  thus no samples were taken during the wash. We found
that  the model predictions were again in good agreement
with experimental data (predicted component percentages
within 3%).
5.  Concluding  remarks
The development and validation of a predictive mechanis-
tic  model of industrial biopharmaceutical multi-component
chromatography has been described. The equilibrium disper-
sive  model with a competitive Langmuir isotherm was  able
to  successfully predict product quality for an extended range
of  inlet concentrations, load challenges and inlet product
distributions. We  used targeted small scale experimenta-
tion for initial model calibration, spending extra effort on
micro  well batch adsorption experiments for the estimation
of  the adsorption isotherm parameters. Then an iterative
procedure was  employed where laboratory scale column
runs  of the industrial process were used to reﬁne param-
eters  in a sequential manner until model predictions were
in  satisfactory agreement with the experimental data. Final
model  predictions were  within 3% of the ﬁnal products’
monomer subunit ratio found in the chromatography elu-
tion  peaks during validation studies. The model was  also
able  to accurately predict the product form distribution in
samples  taken during the wash phase of the chromato-
graphic cycle in validation runs A, B and C (samples were
not  taken in runs D and E). The model can now be used
in  subsequent studies to explore the effect of load mate-
rial  on product quality. The results demonstrate how good
understanding of an industrial process can facilitate simpler
model  development when an exhaustive description is not
required,  despite considering a chromatographic biosepara-
tion  with crude feed material and challenging puriﬁcation
objectives.
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methods
A.1.  Chromatography  resin  and  equipment
Butyl Sepharose 4B fast ﬂow hydrophobic interaction resin
was  obtained from GE Healthcare (Uppsala, Sweden). All
preparative scale laboratory experiments were carried out
using  an ÄKTA FPLC chromatography system from GE Health-
care  (Uppsala, Sweden). Laboratory columns were 1.1 cm
in  diameter and 7.4 cm in bed height. Tosoh Bioscience
TSKgel Phenyl-5PW RP and GE Healthcare Mono S column
(5.0  mm × 50 mm)  high performance liquid chromatography
(HPLC) columns were  used for in assays.
A.2.  Cation  exchange  HPLC  assay
The cation exchange (CEX) HPLC assay utilises a Mono S
column  and a gradient of sodium acetate, acetonitrile and
sodium  chloride at pH 5.0 in order to determine the relative
percentages of the six dimer isoforms of the product in the
sample.  After equilibrating the column for 30 min, 100 l sam-
ples  at 0.5 mg/ml  are injected onto a column at a ﬂowrate
of  1 ml/min. Over the course of the gradient, separation of
the  isoforms is accomplished based upon competitive ionic
exchange  of the sample ions with a counter ion in the mobile
phase,  for ﬁxed cationic functional groups on the column
resin.  Absorbance at 280 nm is measured at the column exit.
Integration  of the resulting chromatogram and analysis of the
relative  percentage area of each peak indicates the percent-
age  of each isoform in the sample. The total time to run each
sample  is 30 min.
A.3.  Phenyl  reverse  phase  HPLC  assay
The phenyl reversed phase (RP) HPLC assay utilises
a  TSK-Phenyl reversed phase column and a
water/acetonitrile/triﬂuoroacetic acid gradient system to
determine  the relative amount of product and product related
impurities  in samples. After equilibrating the column for
30  min, 100 l samples at 1 mg/ml  are injected onto a column
equilibrated with a low percentage of acetonitrile mobile
phase  at a ﬂowrate of 1 ml/min. As the organic modiﬁer
(acetonitrile) is increased over the course of the gradient,
separation of the product related species and impurities is
accomplished. Absorbance at 214 nm is measured at the
column  exit. Integration of the resulting chromatogram and
analysis  of the relative percentage area of each peak indicates
the  percentage of each species in the sample. The total time
to  run each sample is 80 min.
A.4.  Hydrophobic  interaction  chromatography
During all runs the columns were  ﬁrst equilibrated with 50 mM
Tris,  1.0 M NaC1, 0.50 M Arg-HCl, pH 7.00 equilibration buffer.
Isocratic  experiments were  then conducted. The elution peak
from  a preceding pseudo afﬁnity capture chromatography unit
operation was  brought to the correct NaCl concentration and
applied  to the column at 0.49 ml/min followed by a 10 column
volume  (CV) wash step using the equilibration buffer. Elution
buffer  consisting of 20% propylene glycol, 50 mM Tris, 0.50 M
Arg-HCl,  pH 7.00 was  then applied and the product peak col-
lected.  Any remaining bound protein was  removed using 0.1 M
sodium  acetate, pH 4.00 sanitisation buffer, and the columnwas  stored in storage buffer when not in use. All experiments
were conducted between 4 and 8 ◦C.
A.5.  High  throughput  batch  adsorption
Batch binding studies were conducted in a 96-well ﬁlter
plate.  The ﬁlter plates used throughout the experiments were
round-well  800 l plates with 0.45-m pore-size polypropyl-
ene membrane. 25 l of resin was taken from a bulk reservoir
and  dispensed by the robotic liquid handler into the individual
wells  as 25% (v/v) slurry in the appropriate equilibration buffer.
The  plate was then centrifuged to evacuate excess liquid and
leave  damp resin. Subsequently, other solutions composed
of  pure product, having various total protein concentrations
(0.5–1 mg/ml) and isoform distributions (each component was
varied  between 20% and 60%) were added into wells con-
taining  the resin. The initial concentration and component
distribution for each ﬁlter plate well were fashioned by mix-
ing  together protein from a bulk solution of known component
distribution and concentration, with the appropriate amount
of  equilibration buffer from a bulk solution in order that the
total  volume of liquid dispensed into each well was  275 l
(Vtot). The resin and solutions were then agitated on a platform
shaker  for 120 min. Separate batch uptake studies indicated
that  equilibrium was  reached in less than 30 min, and there-
fore  that this incubation time was suitable. Foil adhesive tape
was  used on the underside of the ﬁlter-plate to prevent liquid
loss  during shaking. After incubation, a centrifuge evacuated
the  supernatant into a UV-transparent 96 well microplate
which was  stacked beneath the ﬁlter plate for analysis. The
supernatant  was  then analysed by a 96-well UV spectropho-
tometer (SpectraMax 250, Molecular Devices, Sunnyvale, CA)
to  determine the concentration of protein in the supernatant,
Cm
i
. CEX HPLC was  used to determine the percentage of each
component in the supernatant, Pm
i
. The concentration of the
protein  in the mobile phase is then calculated from Eq. (A1).
Cmi =
Cequil · Pmi
100
(A1)
where Cm
i
is the concentration of component i in the mobile
phase  in mg/ml, Cequil is the measured concentration in
the  supernatant of the micro well, determined by UV  spec-
troscopy,  and Pm
i
is the percentage of component i in the
mobile  phase as determined by CEX HPLC. An elution cycle
was  then conducted following the same methodology as the
load  cycle, where 275 l of elution buffer was added to each
well,  the plate agitated on a platform shaker for 120 min  and
the  supernatant subsequently collected as described previ-
ously  and analysed using the spectrophotometer and CEX
HPLC.  The total amount of protein added to each micro well
was  then determined by Eq. (A2).
Mt = Celution
Velution
+ Cequil
Vequil
(A2)
where Mt is the total amount of protein added to the micro well
(mg),  Celution is the concentration of the elution supernatant
(mg/ml), Velution is the volume of the elution supernatant (ml),
Cequil is the concentration of the equil supernatent (mg/ml),
and  Vequil is the volume of the equil supernatant. The amount
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Lf protein adsorbed per unit volume settled resin, qi, is calcu-
ated  using Eq. (A3).
i =
((Mt · Ploadi /100) − (Cmi · Vequil/1000))
Vresin
(A3)
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